Dr. Khaled Jamoor, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $870.06 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $183.48 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $166.45 | 3 | $0 (2023) |
| Amgen Inc. | $119.30 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $115.65 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $102.85 | 5 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $75.31 | 3 | $0 (2023) |
| Boston Scientific Corporation | $37.98 | 2 | $0 (2022) |
| ABBVIE INC. | $27.86 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $24.69 | 1 | $0 (2022) |
| Cumberland Pharmaceuticals, Inc. | $16.49 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.62 | 2 | Janssen Pharmaceuticals, Inc ($37.62) |
| 2023 | $198.85 | 9 | Janssen Pharmaceuticals, Inc ($48.59) |
| 2022 | $353.71 | 11 | E.R. Squibb & Sons, L.L.C. ($138.49) |
| 2021 | $35.59 | 2 | BOSTON SCIENTIFIC CORPORATION ($18.95) |
| 2020 | $124.99 | 1 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2019 | $119.30 | 1 | Amgen Inc. ($119.30) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Cardiovascular | ||||||
| 06/28/2023 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 05/04/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Cardiology | ||||||
| 04/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: Cardiovascular | ||||||
| 01/04/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Cardiology | ||||||
| 12/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: WATCHMAN_IC | ||||||
| 07/15/2022 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.39 | General |
| Category: Cardiology | ||||||
| 06/30/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Cardiovascular | ||||||
| 06/23/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $122.76 | General |
| Category: Cardiovascular | ||||||
| 06/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL - VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: VASCULAR | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 962 | 2,079 | $627,643 | $165,381 |
| 2022 | 7 | 836 | 1,819 | $504,953 | $134,622 |
| 2021 | 6 | 371 | 692 | $199,132 | $56,812 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 497 | 1,599 | $431,730 | $113,724 | 26.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 299 | 310 | $121,830 | $32,393 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 121 | 124 | $55,428 | $14,365 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $8,865 | $2,329 | 26.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 19 | $7,714 | $2,064 | 26.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 12 | $2,076 | $507.10 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 389 | 1,332 | $326,340 | $86,721 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 247 | 258 | $92,622 | $24,798 | 26.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 94 | 95 | $44,555 | $11,883 | 26.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 46 | $16,146 | $4,369 | 27.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $14,301 | $3,870 | 27.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 49 | $6,615 | $1,797 | 27.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 18 | $4,374 | $1,184 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 153 | 412 | $97,644 | $27,768 | 28.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 112 | 115 | $40,135 | $11,512 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 101 | $34,037 | $9,792 | 28.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 29 | $13,137 | $3,739 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $11,952 | $3,392 | 28.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 17 | $2,227 | $609.62 | 27.4% |
About Dr. Khaled Jamoor, MD
Dr. Khaled Jamoor, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1841795382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Jamoor, MD has received a total of $870.06 in payments from pharmaceutical and medical device companies, with $37.62 received in 2024. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($870.06).
As a Medicare-enrolled provider, Jamoor has provided services to 2,169 Medicare beneficiaries, totaling 4,590 services with total Medicare billing of $356,815. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Providence, RI
- Active Since 03/27/2018
- Last Updated 05/30/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1841795382
Products in Payments
- CAMZYOS (Drug) $138.49
- LOKELMA (Drug) $124.99
- Prolia (Biological) $119.30
- ENTRESTO (Drug) $115.65
- XARELTO (Drug) $102.85
- Assure WCD (Device) $75.31
- ELIQUIS (Drug) $44.99
- DALVANCE (Drug) $27.86
- MULTAQ (Drug) $24.69
- BRILINTA (Drug) $24.04
- WATCHMAN Access System (Device) $19.03
- GENERAL - VASCULAR INTERVENTION (Device) $18.95
- FARXIGA (Drug) $17.42
- CALDOLOR (Drug) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Providence
Saima Chaudhry, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $90,303
Warren Huber, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,280
Prarthana Prakash, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $30,933
Dr. Matthew Hadfield, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $9,754
Dr. Traci Bologna-Jill, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $3,971
Dr. Hana Ajouz, Medical Doctor, MEDICAL DOCTOR
Student in an Organized Health Care Education/Training Program — Payments: $3,950